Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells

International Journal of Cancer

Volumn 81, Issue 5, 1999, Pages 829-834

  Pergolizzi, Rossana ^a   Appierto, Valentina ^a   Crosti, Mariacristina ^a   Cavadini, Elena ^a   Cleris, Loredana ^a   Guffanti, Alessandro ^a   Formelli, Franca ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; FENRETINIDE; RECEPTOR SUBUNIT; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ARTICLE; CARCINOGENICITY; CARCINOMA CELL; CELL CLONE; CONTROLLED STUDY; DRUG SENSITIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0032907350     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990531)81:5<829::AID-IJC26>3.0.CO;2-3     Document Type: Article

References (24)

1. CHIESA, F. and 17 OTHERS, Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results. Oral Oncol. Europ. J. Cancer B, 28, 97-102 (1992).
2. DE PALO, G., VERONESI, U., CAMERINI, T., FORMELLI, F., MASCOTTI, G., BONI, C., FOSSER, V., DEL VECCHIO, M., CAMPA, T., COSTA, A. and MARUBINI, E., Can fenretinide protect women against ovarian cancer? J. nat. Cancer Inst., 87, 146-147 (1995).
3. FANJUL, A., DELIA, D., PIEROTTI, M., RIDEOUT, D., QIU, J. and PFAHL, M., 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. biol. Chem., 271, 22441-22446 (1996).
4. FORMELLI, F., BARUA, A.B. and OLSON, J.A., Bioactivities of N-(4-hydroxyphenyl)retinamide and retinoyl β-glucuronide. FASEB J., 10, 1014-1024 (1996).
5. FORMELLI, F., CLERICI, M., CAMPA, T., DI MAURO, M.G., MAGNI, A., MASCOTTI, G., MOGLIA, D., DE PALO, G., COSTA, A. and VERONESI, U., Five year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J. clin. Oncol., 11, 2036-2042 (1993).
6. FORMELLI, F. and CLERIS, L., Synthetic retinoid fenretinde is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity. Cancer Res., 53, 5374-5376 (1993).
7. HOULE, B., ROCHETTE-EGLY, C. and BRADLEY, W.E.C., Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc. nat. Acad. Sci. (Wash.), 90, 985-989 (1993).
8. KAZMI, S.M.I., PLANTE, R.K., VISCONTI, V. and LAU, C.Y., Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. Cancer Res., 56, 1056-1062 (1996).
9. MANGELSDORF, D.J., THUMMEL, C., BEATO, M., HERRLICH, P., SCHUTZ, G., UMESONO, K., BLUMBERG, B., KASTNER, P., MARK, M., CHAMBON, P. and EVANS, R.M., The nuclear receptor superfamily: the second decade. Cell, 83, 835-839 (1995).
10. LOTAN, R., XU, X.-C., LIPPMAN, S.M., RO, J.Y., LEE, J.S., LEE, J.J. and HONG, W.K., Suppression of retinoic acid receptor-β in premalignant oral lesions and its upregulation by isotretinoin. N. Engl. J. Med., 332, 1405-1410 (1995).
11. MOASSER, M.M., REUTER, V.E. and DMITROVSKY, E., Overexpression of the retinoic acid receptor γ directly induces terminal differentiation of human embryonal carcinoma cells. Oncogene, 10, 1537-1543 (1995).
12. MOGLIA, D., FORMELLI, F., BALIVA, G., BONO, A., ACCETTURRI, M., NAVA, M. and DE PALO, G., Effects of topical treatment with fenretinide (4-HPR) and plasma vitamin A levels in patients with actinic keratoses. Cancer Lett., 110, 87-91 (1996).
13. ORIDATE, N., SUZUKI, S., HIGUCHI, M., MITCHELL, M.F., HONG, W.K. and LOTAN, R., Involvement of reactive oxygen species in N-(4-hydroxyphenyl) retinamide-induced apoptosis in cervical carcinoma cells. J. nat. Cancer Inst., 89, 1191-1198 (1997).
14. PFAHL, M., Nuclear receptor/AP-1 interaction. Endocrinol. Rev., 14, 651-658 (1993).
15. SABICHI, A.L., HENDRICKS, D.T., BOBER, M.A. and BIRRER, M.J., Retinoic acid receptor β expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide. J. nat. Cancer Inst., 90, 597-605 (1998).
16. SHEIKH, M.S., SHAO, Z.-M., LI, X.-S., ORDONEZ, J.V., CONLEY, B.A., WU, S., DAWSON, M.I., HAN, Q.-X., CHAO, W., QUICK, T., NILES, R.M. and FONTANA, J.A., N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis, 16, 2477-2486 (1995).
17. SUPINO, R., CROSTI, M., CLERICI, M., WALTERS, A., CLERIS, L., ZUNINO, F. and FORMELLI, F., Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Int. J. Cancer, 65, 491-497 (1996).
18. SWANSON, B.N., NEWTON, D.L., ROLLER, P.P. and SPORN, M.B., Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents. J. Pharmacol. exp. Ther., 219, 632-637 (1981).
19. SWISSHELM, K., RYAN, K., LEE, X., TSOU, H.C., PEACOCKE, M. and SAGER, R., Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differentiation, 5, 133-141 (1994).
20. TRADATI, N., CHIESA, F., ROSSI, N., GRIGOLATO, R., FORMELLI, F., COSTA, A. and DE PALO, G., Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett., 76, 109-111 (1994).
21. U.K. COORDINATING COMMITTEE ON CANCER RESEARCH, UKCCCR guidelines for the welfare of animals in experimental neoplasia. Brit. J. Cancer, 58, 109-113 (1988).
22. WIDSCHWENDTER, M., BERGER, J., DAXENBICHLER, G., MULLER-HOLZNER, E., WIDSCHWENDTER, A., MAYR, A., MARTH, C. and ZEIMET, A.G., Loss of retinoic acid receptor β expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res., 57, 4158-4161 (1997).
23. XU, X.-C., RO, J.Y., LEE, J.S., SHIN, D.M., HONG, W.K. and LOTAN, R., Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res., 54, 3580-3587 (1994).
24. XU, X.-C., SOZZI, G., LEE, J.S., LEE, J.J., PASTORINO, U., PILOTTI, S., KURIE, J.M., HONG, W.K. and LOTAN, R., Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: implications for lung cancer development. J. nat. Cancer Inst., 89, 624-629 (1997).